FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.
Chen R, Li D, Zheng M, Chen B, Wei T, Wang Y, Li M, Huang W, Tong Q, Wang Q, Zhu Y, Fang W, Guo L, Fang S.
Chen R, et al. Among authors: zhu y.
J Cell Mol Med. 2020 Feb;24(3):2123-2134. doi: 10.1111/jcmm.14763. Epub 2020 Jan 19.
J Cell Mol Med. 2020.
PMID: 31957179
Free PMC article.